A judge has rejected Aristocratās bid for orders requiring competitor Light & Wonder to hand over documents to be placed āin an envelopeā for speedy production should its appeal of a decision ordering that it produce the documents to Aristocrat for possible trade secrets suit fail.
The Australian Securities and Investments Commission has prevailed in its case against payday lenders Cigno and BSF Solutions alleging they provided credit without a licence, with a judge rejecting their argument that their loan model was analogous to buy now, pay later arrangements that donāt require a credit licence.
A class action against Toyota alleging it installed diesel defeat devices in several models of its vehicles has lost a bid to access source code for the carsā emissions control systems, with a judge finding it was not relevant to any current fact in issue.Ā
A judge has granted leave to law firm Levitt Robinson to challenge a ruling cutting $1.14 million of its fees from a settled class action against retirement home operator Aveo, finding the appeal was sufficiently arguable.
Australiaās largest brick manufacturer Brickworks has accused a rival founded by billionaire Len Buckeridge of substantially lessening competition in Western Australia through a 2021 acquisition and engaging in predatory pricing that caused it to shut its doors in the state.
A class action against BPS Financial may abandon some claims after a judge found in a separate case brought by the Australian Securities and Investments Commission that the Qoin cryptocurrency issuer made false and misleading claims about its product.
The chair of the Medibank board has given evidence that he engaged King & Wood Mallesons to commission expert reviews in the wake of a cyberattack, including three reports by Deloitte, after hearing rumours of class action investigations in October 2022.Ā
Challenging a ruling that it breached its continuous disclosure obligations, ANZ has argued on appeal that it did not need to inform the ASX of a bailout by the underwriters of a 2015 institutional share placement because the information didnāt go to the fundamental value of its shares.
Seeking leave to challenge a decision that shaved $1.14 million from its costs in running a class action against Aveo, Levitt Robinson has argued the firm would have enjoyed a right of appeal if it had been joined to the case as it ought to have been.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.